Cardiff University researchers find urolithin A from pomegranates protects arteries from plaque and inflammation
Updated
Updated · SciTechDaily · Apr 27
Cardiff University researchers find urolithin A from pomegranates protects arteries from plaque and inflammation
9 articles · Updated · SciTechDaily · Apr 27
The study, published in Antioxidants, showed that Urolithin A reduced plaque size and inflammation in LDL receptor-deficient mice after twelve weeks, without lowering cholesterol levels.
Urolithin A, produced by gut bacteria from pomegranate polyphenols, stabilized plaques and improved immune and metabolic markers, suggesting benefits beyond cholesterol reduction in atherosclerosis models.
Researchers highlight that individual gut microbiome differences may affect urolithin A production, and note that human studies are needed to confirm these findings for cardiovascular disease prevention strategies.
Since most people can't produce it, is urolithin A the next big heart supplement?
This molecule fights plaque without lowering cholesterol. How is that possible?
Can a gut test reveal if eating pomegranates will actually protect your heart?
If a gut metabolite can prevent heart disease, what else are our microbes doing?
When will human trials confirm this heart health breakthrough from our gut bacteria?
Could targeted probiotics become a future prescription for an unhealthy heart?